Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Saturday Links

Posted on August 17, 2024August 16, 2024 by John C. Goodman

“The projected $4.7 billion spent on migrant services in FY 2025 either eclipses or approximates what New York City will spend on core public services such as sanitation and the fire department.”

Organ transplants: “While most organs are delivered successfully, some organs are delayed in transit, lose viability, and have to be thrown away. Some just get lost, too.”

What’s wrong with the IRA bill:  “Electricity prices have skyrocketed by 30% since 2021, rising 13 times faster than in the previous seven years. Meanwhile, gas prices have more than doubled since Biden took office. Rising energy costs have also been a major driver of food inflation, forcing Americans to spend over 11% of their disposable income on food—the highest percentage in three decades.”   (Recommended)

More than four years since the advent of Covid, public authorities keep pushing health practices contrary to medical and scientific knowledge.

Goldman Sachs estimates that taxpayers will shell out a staggering $1.2 trillion—over three times the initial prediction—to fund the IRA’s green energy subsidies.

Biden exaggerates the benefit of price negotiations for 10 drugs: “overall numbers tied to the amount Medicare actually pays for drugs that show discounts of roughly 22% on the 10 drugs collectively, compared to what the program paid last year. That’s more modest than the exaggerated discounts based on list prices that show price reductions of up to 79%.” And patients only pay a small fraction of the 22%. (STAT: gated)

Charles River Laboratories, a top research contractor that helps drug makers with clinical trials, warns that pharmaceutical companies are slashing research and development owing to the IRA’s drug price controls. (WSJ)

Join the conversation.Cancel reply

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 36 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom